Suketu Sanghvi
Corporate Officer/Principal chez Par Pharmaceutical, Inc.
Profil
Suketu Sanghvi is currently a Senior Vice President-Research & Development at Par Pharmaceutical, Inc. Prior to this, he held positions such as Senior Director-Product Development at Novel Laboratories, Inc., Manager-Formulation & Process Validation at Forest Laboratories, Inc., Vice President-Research and Development at Endo Generics Holdings, Inc., Senior Manager-Formulation at Progenics Pharmaceuticals, Inc., and Principal Scientist-Formulation at Purdue Pharma LP.
Sanghvi holds a doctorate degree from the University of Toronto, a graduate degree from the University of Saskatchewan, and an undergraduate degree from the University of Mysore.
Postes actifs de Suketu Sanghvi
| Sociétés | Poste | Début |
|---|---|---|
Par Pharmaceutical, Inc.
 Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Par Pharmaceutical, Inc. manufactures and markets generic drugs and pharmaceuticals products. It produces drugs for hypertension, inflammation, depression and pain. The firm distributes its products in the semi-solid form of a cream. The company was founded in 1978 and is headquartered in Chestnut Ridge, NY. | Corporate Officer/Principal | - |
Anciens postes connus de Suketu Sanghvi
| Sociétés | Poste | Fin |
|---|---|---|
| PAR PHARMACEUTICAL COMPANIES, INC. | Corporate Officer/Principal | 01/03/2020 |
Purdue Pharma LP
 Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Corporate Officer/Principal | - |
| PROGENICS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
| FOREST LABORATORIES, INC. | Corporate Officer/Principal | - |
Novel Laboratories, Inc.
 Novel Laboratories, Inc. Drugstore ChainsRetail Trade Novel Laboratories, Inc. manufactures and sells compressors. It also provides development and manufacturing services for other pharmaceutical research-based and generic pharmaceutical companies. The firm specializes in the development and manufacture of orally-disintegrating, liquid, modified-release, powder, and rectal dosage forms; immediate-release and chewable tablets, immediate-release and modified-release capsules, semi-solids, rectal gels, and rectal suppositories. The company was founded by Veerappan Sellappan Subramanian in December 2006 and is headquartered in Somerset, NJ. | Corporate Officer/Principal | - |
Formation de Suketu Sanghvi
| University of Mysore | Undergraduate Degree |
| University of Saskatchewan | Graduate Degree |
| University of Toronto | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Novel Laboratories, Inc.
Novel Laboratories, Inc. Drugstore ChainsRetail Trade Novel Laboratories, Inc. manufactures and sells compressors. It also provides development and manufacturing services for other pharmaceutical research-based and generic pharmaceutical companies. The firm specializes in the development and manufacture of orally-disintegrating, liquid, modified-release, powder, and rectal dosage forms; immediate-release and chewable tablets, immediate-release and modified-release capsules, semi-solids, rectal gels, and rectal suppositories. The company was founded by Veerappan Sellappan Subramanian in December 2006 and is headquartered in Somerset, NJ. | Retail Trade |
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY. | Health Technology |
Endo Generics Holdings, Inc.
 Endo Generics Holdings, Inc. Pharmaceuticals: GenericHealth Technology Endo Generics Holdings, Inc. develops, manufactures, and markets generic pharmaceutical products. It also offers dosage, branded, and generic sterile injectable products. The company was founded in 1978 and is headquartered in New York, NY. | Health Technology |
Par Pharmaceutical, Inc.
Par Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Par Pharmaceutical, Inc. manufactures and markets generic drugs and pharmaceuticals products. It produces drugs for hypertension, inflammation, depression and pain. The firm distributes its products in the semi-solid form of a cream. The company was founded in 1978 and is headquartered in Chestnut Ridge, NY. | Health Technology |
Purdue Pharma LP
Purdue Pharma LP Pharmaceuticals: MajorHealth Technology Purdue Pharma LP engages in the development and provision of prescription medicines. It offers a portfolio of medical products in categories, including prescription opioids, sleep, laxatives, antiseptics, and dietary supplement. The company was founded by Raymond R. Sackler in 1991 and is headquartered in Stamford, CT. | Health Technology |